Atara Biotherapeutics Inc Annual Shareholders Meeting Transcript
Good morning. I'm Anhco Cokey Nguyen, and I am the President and Chief Executive Officer and a member of the board of Atara Biotherapeutics. I'm very happy to welcome you to the Atara Biotherapeutics 2026 Annual Meeting of Shareholders.
Before I call the meeting to order, I'd like to introduce to you the members of the board and members of the business team who are with us today via teleconference.
The members of the board with us virtually today are Greg Ciongli, Chair of the Board; Matthew Fust; William Heiden; James Huang; and Nachi Subramanian. The officers of the company with us virtually today are Yanina Grant-Huerta, Chief Accounting Officer; James Sesic, Senior Vice President, Regulatory Affairs; as well as John Chao, our Head of Legal.
I would also like to introduce Sean Kennedy of Deloitte Touche LLP, the company's independent registered public accounting firm; and Carlton Fleming of Sidley Austin LLP, the company's outside legal counsel, who are also in attendance virtually and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
